• Sep 15, 2026

  $102.03-1.03%

  Abbott shares fell 1.03%, a move roughly in line with comparable pharmaceutical companies, which slipped 0.81% on average, with five of six peers lower [1].

  • 1Peer group

• Sep 14, 2026

  $103.09+1.12%

  Abbott shares rose 1.12%, a move that came alongside a broader advance among comparable pharmaceutical companies, which gained 0.92% on average with five of six peers higher [2]. Seeking Alpha reported that Abbott reached a $385 million settlement with the Department of Justice over an infant formula recall [1].

  • 1Seeking Alpha
  • 2Peer group

• Sep 11, 2026

  $101.95-1.36%

• Sep 10, 2026

  $103.36-1.78%

  Abbott shares fell 1.78%, a steeper decline than the comparable pharmaceutical preparations companies, which moved -0.80% on average, with 5 of 6 falling and 1 rising [1].

  • 1Peer group

• Sep 9, 2026

  $105.23-0.27%

• Sep 8, 2026

  $105.52-2.59%

  Abbott shares fell 2.59%, closely tracking a decline across comparable pharmaceutical companies, which dropped 2.50% on average with all six peers lower [1]. The move came alongside elevated volume, at 1.5x the trailing average, within a trading range of 3.0% of the day's low [2].

  • 1Peer group
  • 2Market data

• Sep 4, 2026

  $108.33-0.42%

  ABT shares declined 0.42%, a smaller drop than the broader move seen among comparable pharmaceutical companies, which fell 1.64% on average, with all six peers listed lower [1].

  • 1Peer group

Closing prices for ABT. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.